Global Erythropoietin Drugs Market 2017-2021

Published: Mar 2017

Pages: 70

SKU: IRTNTR12169

Snapshot

Global erythropoietin drugs market overview

Technavio’s market research analyst predicts the global erythropoietin drugs market to grow steadily and project an impressive overall revenue of USD 10 billion by 2021. One of the primary drivers for this market is the increase in chronic kidney disease (CKD) and dialysis patient pool.

Get A Free Sample

In terms of geography, EMEA accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The market will typically witness a relatively higher growth rate in countries such as the UK, Germany, Spain, France, and Italy. Also, the induction of erythropoietin biosimilars will support the sale of erythropoietin drugs in the region. Moreover, favourable and flexible healthcare regulations in several countries across the globe will further propel the growth of the global erythropoietin drugs market in the coming years.

Erythropoietin drugs market report: Competitive landscape and key vendors

The global erythropoietin drugs market is moderately fragmented due to the presence of international and regional vendors. These vendors exhibit strong R&D capabilities and have established distribution systems in place. Occasional spurts of competition have also been witnessed from the local manufacturers present in various countries. The entry prospect of new players is medium to low, considering the slow growth and complex nature of the market.

Leading vendors in the market are

F. Hoffmann-La Roche
Amgen
Johnson & Johnson
Kyowa Hakko Kirin

Other prominent vendors in the erythropoietin drugs market include Ahua Pharmaceutical, 3SBio, BIOSIDUS, Biocon, Boehringer Ingelheim, Chugai Pharmaceutical, Celltrion, Intas Pharmaceuticals, Cipla, DAICHI SANKYO, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries, Dragon Pharma, Huaxin High Biotechnology, JCR Pharmaceuticals, Shanghai Kehua Bio-Engineering, LG Life Science, Novartis, Pfizer, Sandoz International, Shenyang Sunshine Pharmaceutical, Shenzhen Sai Bao Er Bio-Pharmaceutical, Sihuan Pharmaceutical, STADA, Uni-Bio Science, and Wanbang Biochemical Pharmaceuticals.

Segmentation by end-users and analysis of the erythropoietin drugs market

Hospital
Retail pharmacies

During 2016, the retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.

Segmentation by application and analysis of the erythropoietin drugs market

Renal disease
Cancer
HIV
Wounds and neural disease

Chemotherapy targets fast-dividing cancer cells and the healthy cells in the body. Cells in the bone marrow are highly sensitive to chemotherapy, which results in the decreased production of red blood cells in the body. Erythropoietin binds to the red blood cell progenitor's surface receptor in the bone marrow and stimulates proliferation, maturation, and differentiation of cells. This helps correct anemia in cancer patients.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Key questions answered in the report include

What will the erythropoietin drugs market size and the growth rate be in 2021?
What are the key factors driving the global erythropoietin drugs market?
What are the key erythropoietin drugs market trends impacting the growth of the market?
What are the challenges to market growth?
Who are the key vendors in the global erythropoietin drugs market?
What are the market opportunities and threats faced by the vendors in the global erythropoietin drugs market?
Trending factors influencing the market shares of the Americas, APAC, and EMEA.
What are the key outcomes of the five forces analysis of the global erythropoietin drugs market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

Market overview
Top-vendor offerings

PART 03: Market research methodology

Research methodology
Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Biosimilars: Overview

Comparative analysis of biosimilars and generics
Biosimilars market opportunities
Challenges for new entrants

PART 06: Erythropoietin: An overview

Clinical uses of EPO
Abusive uses of EPO
Risks of EPO use

PART 07: Market landscape

Market overview
Five forces analysis

PART 08: Pipeline portfolio

Phase III pipeline portfolio
Phase II pipeline portfolio
Phase I pipeline portfolio
Pre-clinical pipeline portfolio

PART 09: Marketed products portfolio

PART 10: Market segmentation by end-user

Hospitals
Retail pharmacies

PART 11: Market segmentation by application

End-stage renal disease
Cancer
HIV
Wounds and neural disease

PART 12: Market segmentation by product

First-generation erythropoietin formulation
Second-generation erythropoietin formulation
Biosimilars

PART 13: Geographical segmentation

PART 14: Market drivers

Rise in number of patent expiries
Need for cost-effective treatment
Increase in CKD and dialysis patient pool

PART 15: Impact of drivers

PART 16: Market challenges

Physicians' reluctance to prescribe biosimilars
Multiple manufacturing complexities
Development of alternative therapies
Complicated regulatory framework

PART 17: Impact of drivers and challenges

PART 18: Market trends

Advent of biosimilars expected to improve the treatment rates
Outsourcing of biosimilar manufacturing activities
High growth in the emerging markets

PART 19: Vendor landscape

Competitive scenario
Other prominent vendors

PART 20: Key vendor analysis

F. Hoffmann-La Roche
Amgen
Johnson & Johnson
Kyowa Hakko Kirin

PART 21: Appendix

List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis